These were used to confirm prior anti-toxin ELISA screening of cutaneous Anthrax patients, exposed woolworkers and vaccine sera using routine diagnostic methods and establish anti-toxin titers for IgA (See Supplementary Information S1). This evidence concerns the gene CD79A and anthrax infection.